Cargando…

Evaluation of the RABBIT Risk Score for serious infections

OBJECTIVE: To evaluate the Rheumatoid Arthritis Observation of Biologic Therapy (RABBIT) Risk Score for serious infections in patients with rheumatoid arthritis (RA). METHODS: The RABBIT Risk Score for serious infections was developed in 2011 on a cohort of RA patients enrolled in the German biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zink, A, Manger, B, Kaufmann, J, Eisterhues, C, Krause, A, Listing, J, Strangfeld, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145466/ https://www.ncbi.nlm.nih.gov/pubmed/23740236 http://dx.doi.org/10.1136/annrheumdis-2013-203341

Ejemplares similares

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
por: Meissner, Y, et al.
Publicado: (2017)

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
por: Richter, A, et al.
Publicado: (2016)

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
por: Strangfeld, A, et al.
Publicado: (2011)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT
por: Gerhold, Kerstin, et al.
Publicado: (2015)

Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort
por: Baganz, Lisa, et al.
Publicado: (2017)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
por: Mercer, Louise K, et al.
Publicado: (2017)

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
por: Strangfeld, Anja, et al.
Publicado: (2010)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study
por: Tsao, Nicole W, et al.
Publicado: (2019)

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
por: Song, I-H, et al.
Publicado: (2011)

2453: Serious cardiovascular morbidity and mortality in a cohort of adults with Fontan physiology
por: Weingarten, Angela, et al.
Publicado: (2018)

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
por: Mercer, Louise K, et al.
Publicado: (2017)

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register
por: Listing, Joachim, et al.
Publicado: (2006)

The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study
por: Dixon, W G, et al.
Publicado: (2011)

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
por: Salliot, C, et al.
Publicado: (2009)

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis
por: Ducrocq, Gregory, et al.
Publicado: (2010)

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
por: Dixon, William G, et al.
Publicado: (2012)

The risk of cardiovascular disease following breast cancer by Framingham risk score
por: Gernaat, Sofie A. M., et al.
Publicado: (2018)

Sustainability of Rituximab Therapy in Different Treatment Strategies: Results of a 3-Year Followup of a German Biologics Register
por: Richter, Adrian, et al.
Publicado: (2014)

Serious bacterial infections and antibiotic prescribing in primary care: cohort study using electronic health records in the UK
por: Gulliford, Martin C, et al.
Publicado: (2020)

Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020
por: Albrecht, Katinka, et al.
Publicado: (2023)

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48
por: Song, I-H, et al.
Publicado: (2011)

Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
por: Meissner, Yvette, et al.
Publicado: (2016)

Cross-sectional study of chronic hepatitis B virus infection in Rwandan high-risk groups: unexpected findings on prevalence and its determinants
por: Umutesi, Justine, et al.
Publicado: (2021)

Polygenic Risk Scores and Physical Activity
por: KUJALA, URHO M., et al.
Publicado: (2020)

Is the Rheumatoid Arthritis Impact of Disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database
por: Thiele, Katja, et al.
Publicado: (2022)

Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia: a simple algorithm to identify those at high risk of chlamydia infection
por: Wand, Handan, et al.
Publicado: (2011)

A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk
por: Yarwood, Annie, et al.
Publicado: (2015)

Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection
por: Wand, Handan, et al.
Publicado: (2012)

Common infection-related conditions and risk of lymphoid malignancies in older individuals
por: Anderson, L A, et al.
Publicado: (2014)

The risk of cancer in HIV-infected people in southeast England: a cohort study
por: Newnham, A, et al.
Publicado: (2005)

Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020
por: Lee, Charlotte, et al.
Publicado: (2021)

Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study
por: Bouillon, Kim, et al.
Publicado: (2013)

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
por: Schäfer, Martin, et al.
Publicado: (2020)

Prevalence of potentially serious alcohol–medication interactions in older adults in a community pharmacy setting: a cross-sectional study
por: Holton, Alice E, et al.
Publicado: (2020)

Factors associated with serious psychological distress during the COVID-19 pandemic in Japan: a nationwide cross-sectional internet-based study
por: Yoshioka, Takashi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eku1rru8hlli441l0rq6cpe0cr